Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.

Don't forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic!

Andrea Ciorba
Primo
;
Virginia Corazzi;Chiara Bianchini;Stefano Pelucchi
Penultimo
;
Stavros Hatzopoulos
Ultimo
2020

Abstract

Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.
2020
Ciorba, Andrea; Corazzi, Virginia; Henryk Skarżyński, Piotr; B Skarżyńska, Magdalena; Bianchini, Chiara; Pelucchi, Stefano; Hatzopoulos, Stavros...espandi
File in questo prodotto:
File Dimensione Formato  
do not forget ototox.pdf

accesso aperto

Descrizione: versione editoriale
Tipologia: Full text (versione editoriale)
Licenza: Creative commons
Dimensione 111.97 kB
Formato Adobe PDF
111.97 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2501339
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 19
social impact